nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accuracy and variability of cardiologist interpretation of single lead electrocardiograms for atrial fibrillation: The VITAL-AF trial
|
Pipilas, Daniel C. |
|
|
265 |
C |
p. 92-103 |
artikel |
2 |
An investigator-sponsored pragmatic randomized controlled trial of AntiCoagulation vs AcetylSalicylic Acid after Transcatheter Aortic Valve Implantation: Rationale and design of ACASA-TAVI
|
Dodgson, Christopher S. |
|
|
265 |
C |
p. 225-232 |
artikel |
3 |
A pragmatic clinical trial assessing the effect of a targeted notification and clinical support pathway on the diagnostic evaluation and treatment of individuals with left ventricular hypertrophy (NOTIFY-LVH)
|
Berman, Adam N. |
|
|
265 |
C |
p. 40-49 |
artikel |
4 |
Cardiovascular hospitalizations for Medicare advantage beneficiaries in the United States, 2009 to 2019
|
Oseran, Andrew S. |
|
|
265 |
C |
p. 77-82 |
artikel |
5 |
Center-level factors associated with shorter length of stay following stage 1 palliation: An analysis of the national pediatric cardiology quality improvement collaborative registry
|
Foote, Henry P. |
|
|
265 |
C |
p. 143-152 |
artikel |
6 |
Diagnostic performance of a novel automated CT-derived FFR technology in detecting hemodynamically significant coronary artery stenoses: A multicenter trial in China
|
Ding, Yaodong |
|
|
265 |
C |
p. 180-190 |
artikel |
7 |
Editorial Board
|
|
|
|
265 |
C |
p. iii-iv |
artikel |
8 |
Efficacy and safety of a bolus of half-dose r-SAK prior to primary PCI in ST-elevation myocardial infarction: Rationale and design of the OPTIMA-6 trial
|
Li, Chen |
|
|
265 |
C |
p. 31-39 |
artikel |
9 |
Efficacy and safety of cilostazol-based triple antiplatelet therapy compared with clopidogrel-based dual antiplatelet therapy in patients with acute ST-elevation myocardial infarction undergoing percutaneous coronary intervention: A multicenter, randomized, open-label, phase 4 trial
|
Park, Soohyung |
|
|
265 |
C |
p. 11-21 |
artikel |
10 |
Heart rate and death and hospitalization for heart failure in patients with persistent or permanent atrial fibrillation: Insights from the ARISTOTLE trial
|
Vinereanu, Dragos |
|
|
265 |
C |
p. 132-136 |
artikel |
11 |
Importance of familial predisposition to heart failure to the risk of anthracycline-related cardiotoxicity: A nationwide study
|
Banke, Ann |
|
|
265 |
C |
p. 59-65 |
artikel |
12 |
Information for Readers
|
|
|
|
265 |
C |
p. v |
artikel |
13 |
Intensive heart rhythm monitoring to decrease ischemic stroke and systemic embolism—the Find-AF 2 study—rationale and design
|
Uhe, Tobias |
|
|
265 |
C |
p. 66-76 |
artikel |
14 |
Less bleeding by omitting aspirin in non-ST-segment elevation acute coronary syndrome patients: Rationale and design of the LEGACY study
|
van der Sangen, Niels M.R. |
|
|
265 |
C |
p. 114-120 |
artikel |
15 |
Percutaneous mitral annuloplasty with the Carillon device: Outcomes in proportionate and disproportionate functional mitral regurgitation
|
Kałmucki, Piotr |
|
|
265 |
C |
p. 137-142 |
artikel |
16 |
Prediction of early death after atrial fibrillation diagnosis using a machine learning approach: A French nationwide cohort study
|
Bisson, Arnaud |
|
|
265 |
C |
p. 191-202 |
artikel |
17 |
Prognostic impact of precipitated cardiac decompensation in symptomatic heart failure with reduced ejection fraction and severe secondary mitral regurgitation
|
Mewton, Nathan |
|
|
265 |
C |
p. 83-91 |
artikel |
18 |
Prognostic value of coronary artery calcium score for the prediction of atherosclerotic cardiovascular disease in participants with suspected nonalcoholic hepatic steatosis: Results from the multi-ethnic study of atherosclerosis
|
Ichikawa, Keishi |
|
|
265 |
C |
p. 104-113 |
artikel |
19 |
Racial differences in low natriuretic peptide levels: Implications for heart failure clinical trials
|
Gangavelli, Apoorva |
|
|
265 |
C |
p. 1-10 |
artikel |
20 |
Randomized controlled trial of urinE chemiStry guided aCute heArt faiLure treATmEnt (ESCALATE): Rationale and design
|
Cox, Zachary L. |
|
|
265 |
C |
p. 121-131 |
artikel |
21 |
Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet therapy in all-comers undergoing PCI
|
Piccolo, Raffaele |
|
|
265 |
C |
p. 153-160 |
artikel |
22 |
Rationale and design of the pullback pressure gradient (PPG) global registry
|
Munhoz, Daniel |
|
|
265 |
C |
p. 170-179 |
artikel |
23 |
Rationale and design of the ULYSS trial: A randomized multicenter evaluation of the efficacy of early Impella CP implantation in acute coronary syndrome complicated by cardiogenic shock
|
Delmas, Clement |
|
|
265 |
C |
p. 203-212 |
artikel |
24 |
Table of Contents
|
|
|
|
265 |
C |
p. i-ii |
artikel |
25 |
Temporal trends in cardiovascular outcomes and costs among patients with type 2 diabetes
|
Williams, Brent A. |
|
|
265 |
C |
p. 161-169 |
artikel |
26 |
The coronary microvascular angina cardiovascular magnetic resonance imaging trial: Rationale and design
|
Bradley, Conor P. |
|
|
265 |
C |
p. 213-224 |
artikel |
27 |
Transforming blood pressure control in primary care through a novel remote decision support strategy based on wearable blood pressure monitoring: The NEXTGEN-BP randomized trial protocol
|
Gnanenthiran, Sonali R |
|
|
265 |
C |
p. 50-58 |
artikel |
28 |
Transthyretin amyloid cardiomyopathy among patients hospitalized for heart failure and performance of an adapted wild-type ATTR-CM machine learning model: Findings from GWTG-HF
|
Peters, Anthony E. |
|
|
265 |
C |
p. 22-30 |
artikel |